Frank Giles

1.2k total citations
68 papers, 912 citations indexed

About

Frank Giles is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Frank Giles has authored 68 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 40 papers in Genetics and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Frank Giles's work include Chronic Lymphocytic Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (28 papers) and Acute Myeloid Leukemia Research (18 papers). Frank Giles is often cited by papers focused on Chronic Lymphocytic Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (28 papers) and Acute Myeloid Leukemia Research (18 papers). Frank Giles collaborates with scholars based in United States, United Kingdom and Germany. Frank Giles's co-authors include C. P. Worman, Andrew P. Jewell, A. H. Goldstone, Hagop M. Kantarjian, P M Lydyard, Kwee Yong, Richard M. Stone, Daniel J. DeAngelo, Elihu H. Estey and Judith E. Karp and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Frank Giles

67 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Giles United States	15	504	352	335	188	171	68	912
Yeow Tee Goh Singapore	16	501 1.0×	367 1.0×	243 0.7×	218 1.2×	199 1.2×	101	932
Paola Masolini Italy	17	389 0.8×	187 0.5×	252 0.8×	294 1.6×	157 0.9×	24	849
Claudia Baratè Italy	19	513 1.0×	499 1.4×	225 0.7×	190 1.0×	127 0.7×	56	1.0k
Michal Bar‐Natan United States	15	719 1.4×	364 1.0×	524 1.6×	312 1.7×	157 0.9×	41	1.3k
Devendra Hiwase Australia	20	944 1.9×	489 1.4×	378 1.1×	296 1.6×	172 1.0×	107	1.3k
Radovan Vrḫovac Croatia	15	243 0.5×	330 0.9×	223 0.7×	253 1.3×	157 0.9×	65	810
Christophe Willekens France	18	453 0.9×	255 0.7×	375 1.1×	186 1.0×	162 0.9×	50	946
S. Faderl United States	16	882 1.8×	393 1.1×	417 1.2×	240 1.3×	87 0.5×	24	1.2k
Angela Hamblin United Kingdom	11	207 0.4×	202 0.6×	288 0.9×	179 1.0×	157 0.9×	32	708
Naresh Punwani United States	12	268 0.5×	288 0.8×	178 0.5×	241 1.3×	224 1.3×	17	803

Countries citing papers authored by Frank Giles

Since Specialization

Citations

This map shows the geographic impact of Frank Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Giles more than expected).

Fields of papers citing papers by Frank Giles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Giles. The network helps show where Frank Giles may publish in the future.

Co-authorship network of co-authors of Frank Giles

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Giles. A scholar is included among the top collaborators of Frank Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Giles. Frank Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brümmendorf, Tim H., Carlo Gambacorti‐Passerini, Camille N. Abboud, et al.. (2019). Maintenance of Health-Related Quality of Life in the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase Chronic Myeloid Leukemia. Blood. 134(Supplement_1). 4157–4157. 1 indexed citations

McLaughlin, Fiona, Frank Giles, Francis Sullivan, et al.. (2013). The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance. British Journal of Cancer. 109(8). 2131–2141. 10 indexed citations

DeAngelo, Daniel J., Andrew Spencer, Kapil N. Bhalla, et al.. (2013). Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies. Leukemia. 27(8). 1628–1636. 116 indexed citations

Yin, Ophelia, Frank Giles, Michele Baccarani, et al.. (2012). Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia. Cancer Chemotherapy and Pharmacology. 70(2). 345–350. 18 indexed citations

Adams, David J., Marit Liland Sandvold, Finn Myhren, et al.. (2008). Anti proliferative activity of ELACYT™ (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells. Leukemia & lymphoma. 49(4). 786–797. 26 indexed citations

Jabbour, Elias, et al.. (2007). Nilotinib - A novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond. 10(7). 468–479. 6 indexed citations

Ravandi, Farhad, Iman Jilani, Elihu H. Estey, et al.. (2006). Soluble phosphorylated fms-like tyrosine kinase. Leukemia Research. 31(6). 791–797. 8 indexed citations

Levis, Mark J., Adam Stine, Benjamin D. Smith, et al.. (2005). Pharmacokinetic and Pharmacodynamic Studies of Lestaurtinib (CEP-701) and PKC-412: Cytotoxicity Is Often Dependent on Non-FLT3-Mediated Effects.. Blood. 106(11). 2463–2463. 11 indexed citations

Tsimberidou, Apostolia M., Frank Giles, I. Khouri, et al.. (2004). Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. Annals of Oncology. 16(1). 139–145. 38 indexed citations

10.

Kantarjian, H, Moshe Talpaz, Stephen J. O’Brien, et al.. (1999). Significance of FHIT expression in chronic myelogenous leukemia.. PubMed. 5(12). 4059–64. 9 indexed citations

11.

Jewell, Andrew P., C. P. Worman, Frank Giles, & A H Goldstone. (1997). Serum Levels of TNF, IL-6 and sCD23 Correlate with Changes in Lymphocyte Count in Patients with B-Cell Chronic Lymphocytic Leukaemia Receiving Interferon-Alpha Therapy. Leukemia & lymphoma. 24(3-4). 327–333. 13 indexed citations

12.

Giles, Frank, et al.. (1994). Recombinant Interferon-α ₂ Antibodies in Chronic Lymphocytic Leukemia. Journal of Interferon Research. 14(4). 191–192. 2 indexed citations

13.

Jewell, Andrew P., et al.. (1994). Serum macrophage colony‐stimulating factor (M‐CSF) levels correlate with clinical response to interferon‐alpha in patients with early‐stage B‐CLL. British Journal of Haematology. 86(2). 441–443. 7 indexed citations

14.

Jewell, Andrew P., C. P. Worman, Frank Giles, A. H. Goldstone, & Peter M. Lydyard. (1992). Resistance of Chronic Lymphocytic Leukaemia Cells to Interferon-α Generated Lymphokine Activated Killer Cells. Leukemia & lymphoma. 7(5-6). 473–480. 15 indexed citations

15.

Giles, Frank, John Richards, Jeffrey Tobias, et al.. (1992). Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myeloma. European Journal of Cancer. 28(8-9). 1392–1395. 10 indexed citations

16.

Lim, Seah H., Frank Giles, Mark Smith, & Anthony H. Goldstone. (1991). Bacterial Infections in Lymphoma Patients Treated with Recombinant Interleukin-2. Acta Haematologica. 85(3). 135–138. 10 indexed citations

17.

Lim, Seah H., et al.. (1991). Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias. Cancer Immunology Immunotherapy. 33(2). 133–137. 8 indexed citations

18.

Giles, Frank, Joseph Kearney, Michael J. Mills, et al.. (1990). Systemic Irradiation Therapy of Myelomatosis—The Therapeutic Implications of Technique. Leukemia & lymphoma. 1(3-4). 227–233. 3 indexed citations

19.

Hoffbrand, A. V., et al.. (1990). Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2′,5′ oligoadenylate system and clinical response. British Journal of Haematology. 74(4). 452–456. 17 indexed citations

20.

Singer, Charles R.J., et al.. (1989). Hemibody irradiation. An effective second-line therapy in drug-resistant multiple myeloma. Cancer. 63(12). 2446–2451. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact